2,2'-dipyridyl disulfide has been researched along with HIV Infections in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Bess, J; Blanchard, SC; Chao, CW; Gorman, J; Kwong, PD; Li, W; Li, Z; Lifson, JD; Liu, J; Lu, M; Mothes, W; Terry, DS; Zhang, B; Zhou, T | 1 |
Bess, J; Bhardwaj, N; Chertova, E; Holman, RM; Lifson, J; Miller, E; Sabado, R; Salazar, A; Spadaccia, M; Trubey, CM | 1 |
Babcock, E; Bhardwaj, N; Fru, K; Kaufmann, DE; Kavanagh, DG; Larsson, M; Lifson, J; Lubong Sabado, R; Rosenberg, E; Walker, B | 1 |
Bhardwaj, N; Che, KF; Larsson, M; Lifson, JD; Messmer, D; Sabado, RL; Shankar, EM; Tjomsland, V | 1 |
Andrieu, JM; Guo, W; Lu, W; Lu, Y; Wu, X | 1 |
Cameron, PU; Cunningham, AL; Dable, J; Frank, I; Lifson, JD; Miranda-Saksena, M; Piatak, M; Pope, M; Romani, N; Santos, JJ; Stössel, H; Turville, SG; Wilkinson, J | 1 |
Fitzgerald, W; Grivel, JC; Lifson, JD; Margolis, LB; Sylwester, AW | 1 |
Andrieu, JM; Arraes, LC; Ferreira, WT; Lu, W | 1 |
Arthur, LO; Banks, WA; Bess, JW; Franko, MW; Kumar, VB | 1 |
9 other study(ies) available for 2,2'-dipyridyl disulfide and HIV Infections
Article | Year |
---|---|
Subnanometer structures of HIV-1 envelope trimers on aldrithiol-2-inactivated virus particles.
Topics: 2,2'-Dipyridyl; Cell Line; Cryoelectron Microscopy; Disulfides; Electron Microscope Tomography; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Models, Molecular; Oxidants; Protein Conformation; Protein Multimerization; Solubility; Virion | 2020 |
Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid-poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy.
Topics: 2,2'-Dipyridyl; Adaptive Immunity; AIDS Vaccines; beta-Galactosidase; Carboxymethylcellulose Sodium; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Dendritic Cells; Disulfides; HIV Infections; HIV-1; Humans; Immunotherapy, Adoptive; Poly I-C; Polylysine; Virus Inactivation | 2015 |
In vitro priming recapitulates in vivo HIV-1 specific T cell responses, revealing rapid loss of virus reactive CD4 T cells in acute HIV-1 infection.
Topics: 2,2'-Dipyridyl; Antigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Communication; Dendritic Cells; Disulfides; Epitopes; HIV Infections; HIV-1; Humans; L-Selectin; Leukocyte Common Antigens; Leukocytes, Mononuclear; Lymphocyte Activation; Phenotype | 2009 |
HIV-1 impairs in vitro priming of naïve T cells and gives rise to contact-dependent suppressor T cells.
Topics: 2,2'-Dipyridyl; Antibodies, Blocking; Antigens, CD; Apoptosis Regulatory Proteins; Cell Communication; Cell Proliferation; Cells, Cultured; CTLA-4 Antigen; Dendritic Cells; Disulfides; Forkhead Transcription Factors; HIV Antigens; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Programmed Cell Death 1 Receptor; Signal Transduction; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; TNF-Related Apoptosis-Inducing Ligand | 2010 |
Therapeutic dendritic-cell vaccine for simian AIDS.
Topics: 2,2'-Dipyridyl; AIDS Vaccines; Animals; Antibodies, Viral; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dendritic Cells; Disulfides; Female; HIV Infections; Humans; Immunity, Cellular; Lymph Nodes; Macaca mulatta; Male; Neutralization Tests; Oxidants; RNA, Viral; SAIDS Vaccines; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; T-Lymphocytes, Cytotoxic; Vaccination; Viral Load | 2003 |
Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.
Topics: 2,2'-Dipyridyl; CD4-Positive T-Lymphocytes; Cells, Cultured; Dendritic Cells; Disulfides; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Microscopy, Electron; Protein Binding; Protein Transport; Simian Immunodeficiency Virus; Sulfhydryl Reagents | 2004 |
Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.
Topics: 2,2'-Dipyridyl; B-Lymphocytes; Cells, Cultured; Culture Media, Conditioned; Disulfides; HIV Antibodies; HIV Infections; HIV-1; Humans; Oxidants; Palatine Tonsil; Receptors, CCR5; Receptors, CXCR4; Virion | 2004 |
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection.
Topics: 2,2'-Dipyridyl; Adult; AIDS Vaccines; Brazil; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dendritic Cells; Disulfides; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; HIV Infections; HIV-1; Humans; Interferon-gamma; Interleukin-2; Membrane Glycoproteins; Perforin; Pore Forming Cytotoxic Proteins; T-Lymphocytes, Helper-Inducer; Time Factors; Viral Load | 2004 |
Evidence that the species barrier of human immunodeficiency virus-1 does not extend to uptake by the blood--brain barrier: comparison of mouse and human brain microvessels.
Topics: 2,2'-Dipyridyl; Animals; Blood-Brain Barrier; Brain; Capillaries; Cell Line; Disulfides; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Mice; Species Specificity; Wheat Germ Agglutinins | 2005 |